Akari Therapeutics
AKTX | NASDAQ
$8.10
-$0.15 (-1.82%)
Nov 2, 2026, 10:33 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.6M | -15.76M | -3.23M | -7.4M | -3.12M | -3.53M | -5.28M | -2.93M | -7.45M | -5.99M | -5.09M | -2.51M | -4.62M | -4.59M | -6.01M | -6.01M | -5.82M | -5.24M | -5.87M | -1.46M | -4.33M | -5.55M |
Interest Income | n/a | n/a | n/a | 993.99 | n/a | n/a | 1K | 3K | 2K | 2K | 11.45 | 16K | 29K | 30K | 18.81 | 18.81 | 3.96K | 4.36K | 3.98K | 1.37K | 1.52K | 3.74K |
Pretax Income | -4.81M | -15.31M | -5.21M | -7.49M | -1.9M | -3.71M | -3.77M | -2.9M | -7.56M | -5.57M | -4.14M | -2.87M | -4M | 1M | -3.45M | -3.45M | -5.68M | -5.18M | -5.79M | -1.45M | -4.35M | -5.84M |
Net Income | -4.81M | -14.46M | -5.3M | -6.4M | -1.9M | -3.71M | -3.77M | -2.9M | -7.56M | -5.57M | -4.14M | -2.87M | -4M | 1M | -3.45M | -3.45M | -5.68M | -5.18M | -5.79M | -1.45M | -4.35M | -5.84M |
Selling & General & Admin | 2.53M | 2.17M | 2.14M | 1.98M | 2.45M | 2.71M | 3.05M | 1.71M | 2.24M | 3.7M | 2.58M | 2.82M | 3.09M | 2.86M | 3.73M | 3.73M | 2.97M | 3.1M | 2.02M | 1.89M | 2.15M | 2.02M |
Research & Development | 2.08M | 1.46M | 1.09M | 249K | 667K | 813K | 1.25M | 143K | 3.31M | 2.28M | 5.08M | -314K | 1.52M | 1.73M | 3.44M | 3.44M | 2.85M | 2.14M | 6.92M | -430.16K | 2.18M | 3.53M |
Other Expenses | n/a | 12.13M | -1.5K | 5.18M | n/a | n/a | 983K | 1.08M | 1.89M | -2 | -2.57M | n/a | n/a | n/a | -1.16M | -1.16M | n/a | n/a | -3.07M | n/a | n/a | n/a |
Operating Expenses | 4.6M | 15.76M | 3.23M | 7.4M | 3.12M | 3.53M | 5.28M | 2.93M | 7.45M | 5.98M | 5.09M | 2.51M | 4.62M | 4.59M | 6.01M | 6.01M | 5.82M | 5.24M | 5.87M | 1.46M | 4.33M | 5.55M |
Interest Expense | 80K | 61K | 723K | 120.27K | 50K | 55K | 124K | 69K | 51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.6M | 15.76M | 3.23M | 7.4M | 3.12M | 3.53M | 5.28M | 2.93M | 7.45M | 5.99M | 5.09M | 2.51M | 4.62M | 4.59M | 6.01M | 6.01M | 5.82M | 5.24M | 5.87M | 1.46M | 4.33M | 5.55M |
Income Tax Expense | n/a | -859K | 85K | -1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.79M | 21.04K | 21.04K | 16.33K | 15.74K | 13.65K | 9.7K | 6.1K | 4.71K | 3.36K | 2.2K | 2.53K | 2.53K | 1.89K | 1.71K | 1.71K | 1.48K | 1.34K | 1.19K | 1.16K | 961 | 961 |
Shares Outstanding (Diluted) | 1.79M | 21.04K | 21.04K | 16.33K | 15.74K | 13.65K | 9.7K | 6.1K | 4.71K | 3.36K | 2.2K | 2.53K | 2.53K | 1.89K | 1.71K | 1.71K | 1.48K | 1.34K | 1.19K | 1.16K | 961 | 961 |
EPS (Basic) | -272 | -688 | -248 | -392 | -120 | -272 | -392 | -472 | -1.61K | -1.66K | -1.88K | -1.14K | -1.58K | 528 | -2.02K | -2.02K | -3.83K | -3.86K | -4.86K | -1.25K | -4.52K | -6.07K |
EPS (Diluted) | -272 | -688 | -248 | -392 | -120 | -272 | -392 | -472 | -1.61K | -1.66K | -1.88K | -1.14K | -1.58K | 528 | -2.02K | -2.02K | -3.83K | -3.86K | -4.86K | -1.25K | -4.52K | -6.07K |
EBITDA | -4.73M | -15.25M | -4.49M | -7.37M | -1.85M | -3.65M | -3.65M | -2.83M | -7.51M | -5.55M | -4.14M | -2.87M | -4M | 1M | -3.44M | -3.44M | -5.68M | -5.18M | -5.79M | -1.45M | -4.35M | -5.55M |
EBIT | -4.73M | -15.25M | -4.49M | -7.37M | -1.85M | -3.65M | -3.65M | -2.83M | -7.51M | -5.57M | -4.14M | -2.87M | -4M | 1M | -3.45M | -3.45M | -5.68M | -5.18M | -5.79M | -1.45M | -4.35M | -5.55M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | 13K | 1K | 1K | 1K | 1K | 1.03K | 1.03K | 942 | 1.01K | 1.01K | 1.03K | 1.05K | 1.03K |
Add to Watchlist
Select watchlists to add or remove AKTX